Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             184 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Adrenal cortex ontogenesis Lalli, Enzo
2010
6 p. 853-864
12 p.
artikel
2 Adrenal disease in pregnancy Lekarev, Oksana
2011
6 p. 959-973
15 p.
artikel
3 Amiodarone and thyroid Eskes, Silvia A.
2009
6 p. 735-751
17 p.
artikel
4 Androgen therapy for women after menopause Marko, Kathryn I.

6 p.
artikel
5 Autoimmune diseases and pregnancy Tincani, Angela

6 p.
artikel
6 Autoimmune polyglandular diseases Kahaly, George J.

6 p.
artikel
7 Autoimmunity and the endocrine system: Thyroid, hypophysis and pregnancy Antonelli, Alessandro

6 p.
artikel
8 Best Practice and Research Clinical Endocrinology and Metabolism focusing on Growth Hormone Deficiency in Adults – New Perspectives Yuen, Kevin C.J.

6 p.
artikel
9 Carney complex and other conditions associated with micronodular adrenal hyperplasias Almeida, Madson Q.
2010
6 p. 907-914
8 p.
artikel
10 Causes and pathophysiology of hypoparathyroidism Cianferotti, Luisella
2018
6 p. 909-925
artikel
11 Cellular and molecular mechanisms of mitochondrial function Osellame, Laura D.
2012
6 p. 711-723
13 p.
artikel
12 Central and peripheral roles of vasopressin in the circadian defense of body hydration Gizowski, Claire
2017
6 p. 535-546
artikel
13 Circadian aspects of adipokine regulation in rodents Challet, Etienne
2017
6 p. 573-582
artikel
14 Circadian clock-gastrointestinal peptide interaction in peripheral tissues and the brain Landgraf, Dominic
2017
6 p. 561-571
artikel
15 Classical and non-classical causes of GH deficiency in the paediatric age Di Iorgi, Natascia
2016
6 p. 705-736
32 p.
artikel
16 Classical complications of primary hyperparathyroidism Minisola, Salvatore
2018
6 p. 791-803
artikel
17 Classification of adrenal cortical tumors: Promise of the ‘molecular’ approach Giordano, Thomas J.
2010
6 p. 887-892
6 p.
artikel
18 Classification of adrenal cortical tumors: What limits for the pathological approach? Tissier, Frédérique
2010
6 p. 877-885
9 p.
artikel
19 Clinical implications of Y chromosome microdeletions among infertile men Punjani, Nahid

6 p.
artikel
20 Clinical presentation and management of hypoparathyroidism Marcucci, Gemma
2018
6 p. 927-939
artikel
21 Cognitive health after menopause: Does menopausal hormone therapy affect it? Stute, Petra

6 p.
artikel
22 Comparing treatment with daily and long-acting growth hormone formulations in adults with growth hormone deficiency: Challenging issues, benefits, and risks Höybye, Charlotte

6 p.
artikel
23 Conditions and drugs interfering with thyroxine absorption Liwanpo, Llanyee
2009
6 p. 781-792
12 p.
artikel
24 Congenital absence of the vas deferens: Cystic fibrosis transmembrane regulatory gene mutations Wong, Rachel

6 p.
artikel
25 Corrigendum to “Gender differences and disparities in all-cause and coronary heart disease mortality: Epidemiological aspects” [Clin Endocrinol Metabol (2013) 481–500] Barrett-Connor, Elizabeth
2013
6 p. 831-
1 p.
artikel
26 Current and future treatments of osteoporosis in men Kaufman, Jean-Marc
2014
6 p. 871-884
14 p.
artikel
27 Current and future treatments of secondary osteoporosis Soriano, Raquel
2014
6 p. 885-894
10 p.
artikel
28 Current medical treatment and perspective in gonadotroph tumors Even-Zohar, Naomi

6 p.
artikel
29 Determination of cortisol in serum, saliva and urine Turpeinen, Ursula
2013
6 p. 795-801
7 p.
artikel
30 Determination of human chorionic gonadotropin Stenman, Ulf-Håkan
2013
6 p. 783-793
11 p.
artikel
31 Determination of IGFs and their binding proteins Hjortebjerg, Rikke
2013
6 p. 771-781
11 p.
artikel
32 Determination of insulin for the diagnosis of hyperinsulinemic hypoglycemia De León, Diva D.
2013
6 p. 763-769
7 p.
artikel
33 Diagnosis and management of premature ovarian insufficiency Rahman, Rumana

6 p.
artikel
34 Diagnosis and treatment of GH deficiency in Prader–Willi syndrome Grugni, Graziano
2016
6 p. 785-794
10 p.
artikel
35 Diagnosis of growth hormone deficiency in the paediatric and transitional age Chinoy, A.
2016
6 p. 737-747
11 p.
artikel
36 Diagnostic and therapeutic use of recombinant human TSH (rhTSH) in differentiated thyroid cancer Pacini, Furio
2008
6 p. 1009-1021
13 p.
artikel
37 Differences between bone health parameters in adults with acromegaly and growth hormone deficiency: A systematic review Freda, Pamela U.

6 p.
artikel
38 Differentiation of human pluripotent stem cells into β-cells: Potential and challenges Quiskamp, Nina
2015
6 p. 833-847
15 p.
artikel
39 Disorders of calcium metabolism and parathyroid disease Cooper, Mark S.
2011
6 p. 975-983
9 p.
artikel
40 Drugs that suppress TSH or cause central hypothyroidism Haugen, Bryan R.
2009
6 p. 793-800
8 p.
artikel
41 Dyslipidaemia and growth hormone deficiency – A comprehensive review Hepprich, Matthias

6 p.
artikel
42 Editorial Board
6 p.
artikel
43 Editorial Board 2018
6 p. ii
artikel
44 Editorial Board
6 p.
artikel
45 Editorial Board
6 p.
artikel
46 Editorial Board
6 p.
artikel
47 Editorial Board
6 p.
artikel
48 Efficacy and safety of currently marketed anti-osteoporosis medications Reginster, J.Y.
2014
6 p. 809-834
26 p.
artikel
49 Endocrine disorders & female infertility Unuane, David
2011
6 p. 861-873
13 p.
artikel
50 Endocrine disorders in pregnancy: Physiological and hormonal aspects of pregnancy Feldt–Rasmussen, Ulla
2011
6 p. 875-884
10 p.
artikel
51 Endocrine oncology in pregnancy Lansdown, A.
2011
6 p. 911-926
16 p.
artikel
52 Endocrine rhythms of growth hormone release: Insights from animal studies Steyn, Frederik J.
2017
6 p. 521-533
artikel
53 Environmental pollutants and the thyroid Pearce, Elizabeth N.
2009
6 p. 801-813
13 p.
artikel
54 Epidemiology of parathyroid disorders Rao, Sudhaker D.
2018
6 p. 773-780
artikel
55 Epidemiology of thyroid nodules Dean, Diana S.
2008
6 p. 901-911
11 p.
artikel
56 Epigenetic mechanisms within the sperm epigenome and their diagnostic potential Pollard, Chad A.

6 p.
artikel
57 Evolving function and potential of pancreatic alpha cells Stanojevic, Violeta
2015
6 p. 859-871
13 p.
artikel
58 Exacerbations of autoimmune diseases during pregnancy and postpartum Borba, Vânia Vieira

6 p.
artikel
59 External quality assessment of hormone determinations Sturgeon, Catharine M.
2013
6 p. 803-822
20 p.
artikel
60 Fine-needle aspiration of the thyroid: today and tomorrow Baloch, Zubair W.
2008
6 p. 929-939
11 p.
artikel
61 From substitution of insulin to replacement of insulin producing cells: New therapeutic opportunities from research on pancreas development and stem cell differentiation Zulewski, Henryk
2015
6 p. 815-820
6 p.
artikel
62 Future directions for new medical entities in osteoporosis Ferrari, Serge
2014
6 p. 859-870
12 p.
artikel
63 Genetic causes of isolated and combined pituitary hormone deficiency Giordano, Mara
2016
6 p. 679-691
13 p.
artikel
64 Genetic mutations contributing to non-obstructive azoospermia Peña, Vanessa N.

6 p.
artikel
65 “Genetics of male infertility” Flannigan, Ryan

6 p.
artikel
66 Genetics of parathyroids disorders: Overview Alberto, Falchetti
2018
6 p. 781-790
artikel
67 Genetics of pheochromocytomas and paragangliomas Opocher, Giuseppe
2010
6 p. 943-956
14 p.
artikel
68 Genetics of teratozoospermia: Back to the head Beurois, Julie

6 p.
artikel
69 Genetic underpinnings of asthenozoospermia Tu, Chaofeng

6 p.
artikel
70 GH deficiency in adult survivors of childhood cancer Felicetti, Francesco
2016
6 p. 795-804
10 p.
artikel
71 Growth hormone deficiency in children Prodam, Flavia
2016
6 p. 677-678
2 p.
artikel
72 Growth hormone replacement in adults with cured acromegaly: Efficacy and safety Tritos, Nicholas A.

6 p.
artikel
73 Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy Ragusa, Francesca

6 p.
artikel
74 Hormone therapy and cardiovascular disease: Benefits and harms Maas, Angela H.E.M.

6 p.
artikel
75 Hormone therapy for menopause and premature ovarian insufficiency Lambrinoudaki, Irene

6 p.
artikel
76 Hormone therapy regimens for managing the menopause and premature ovarian insufficiency Armeni, Eleni

6 p.
artikel
77 How best to monitor the specific side effects of medical treatments of Cushing’s disease Castinetti, Frederic

6 p.
artikel
78 Human pluripotent stem cell based islet models for diabetes research Balboa, Diego
2015
6 p. 899-909
11 p.
artikel
79 Hypophysitis: An update on the novel forms, diagnosis and management of disorders of pituitary inflammation Gubbi, Sriram

6 p.
artikel
80 Identification of patient profile for treatment Moon, Rebecca J.
2014
6 p. 767-782
16 p.
artikel
81 Immune reconstitution syndrome and the thyroid Weetman, Anthony
2009
6 p. 693-702
10 p.
artikel
82 Immunotherapy in pituitary carcinomas and aggressive pituitary tumors Raverot, Gérald

6 p.
artikel
83 Impact of long-acting growth hormone replacement therapy in adult growth hormone deficiency: Comparison between adolescent, adult, and elderly patients Kargi, Atil Y.

6 p.
artikel
84 Implication of epigenetics in pancreas development and disease Quilichini, Evans
2015
6 p. 883-898
16 p.
artikel
85 Infertility considerations in klinefelter syndrome: From origin to management Deebel, Nicholas A.

6 p.
artikel
86 Infertility in women with systemic autoimmune diseases Khizroeva, Jamilya

6 p.
artikel
87 Innovative therapeutics in acromegaly Kasuki, Leandro

6 p.
artikel
88 Innovative tumour targeting therapeutics in Cushing's disease von Selzam, Vivian

6 p.
artikel
89 Insights into the autoimmune aspect of premature ovarian insufficiency Sharif, Kassem

6 p.
artikel
90 Interferon induced thyroiditis Tomer, Yaron
2009
6 p. 703-712
10 p.
artikel
91 Is there a role for growth hormone replacement in adults to control acute and post-acute COVID-19? Venugopal, Navneet

6 p.
artikel
92 Kallman syndrome and central non-obstructive azoospermia Thakker, Sameer

6 p.
artikel
93 Keyword index 2009
6 p. I1-
1 p.
artikel
94 Keyword index 2016
6 p. I1-
1 p.
artikel
95 Keyword index 2014
6 p. I1-
1 p.
artikel
96 Keyword index 2012
6 p. I1-
1 p.
artikel
97 Keyword index 2010
6 p. I1-
1 p.
artikel
98 Keyword index 2008
6 p. I1-
1 p.
artikel
99 Keyword index 2013
6 p. I-
1 p.
artikel
100 Keyword index 2015
6 p. I1-
1 p.
artikel
101 Keyword index 2011
6 p. I1-
1 p.
artikel
102 Lithium and thyroid Lazarus, John H.
2009
6 p. 723-733
11 p.
artikel
103 Management of familial hyperparathyroidism syndromes: MEN1, MEN2, MEN4, HPT-Jaw tumour, Familial isolated hyperparathyroidism, FHH, and neonatal severe hyperparathyroidism Cristina, Eller-Vainicher
2018
6 p. 861-875
artikel
104 Management of normocalcemic primary hyperparathyroidism Cusano, Natalie E.
2018
6 p. 837-845
artikel
105 Management of ovarian disease in pregnancy Phelan, Niamh
2011
6 p. 985-992
8 p.
artikel
106 Medications that distort in vitro tests of thyroid function, with particular reference to estimates of serum free thyroxine Stockigt, Jim R.
2009
6 p. 753-767
15 p.
artikel
107 Menopausal hormone therapy and breast cancer risk Rozenberg, Serge

6 p.
artikel
108 Menopausal hormone therapy for the management of osteoporosis Gosset, Anna

6 p.
artikel
109 Menopausal hormone therapy in women with benign gynaecological conditions and cancer Brennan, Annabelle

6 p.
artikel
110 Menopausal hormone therapy in women with medical conditions Kapoor, Ekta

6 p.
artikel
111 Meta-analysis of mortality in adults with growth hormone deficiency: Does growth hormone replacement therapy really improve mortality rates? van Bunderen, Christa C.

6 p.
artikel
112 Metabolic alterations in paediatric GH deficiency Rothermel, Juliane
2016
6 p. 757-770
14 p.
artikel
113 Mild traumatic brain injury as a cause of adult growth hormone deficiency: Diagnosis and treatment Herodes, Megan

6 p.
artikel
114 Mitochondria and endocrine function of adipose tissue Medina-Gómez, Gema
2012
6 p. 791-804
14 p.
artikel
115 Mitochondria in endocrinology Maechler, Pierre
2012
6 p. 709-710
2 p.
artikel
116 Mitochondrial dynamics and morphology in beta-cells Stiles, Linsey
2012
6 p. 725-738
14 p.
artikel
117 Mitochondrial signal transduction in pancreatic β-cells Maechler, Pierre
2012
6 p. 739-752
14 p.
artikel
118 Mitochondrial sirtuins and metabolic homeostasis Pirinen, Eija
2012
6 p. 759-770
12 p.
artikel
119 Models of GH deficiency in animal studies Gahete, Manuel D.
2016
6 p. 693-704
12 p.
artikel
120 Molecular pathogenesis of parathyroid tumours Cinque, Luigia
2018
6 p. 891-908
artikel
121 Molecular pathology of thyroid cancer: diagnostic and clinical implications Fagin, James A.
2008
6 p. 955-969
15 p.
artikel
122 Monitoring of osteoporosis therapy Bruyère, Olivier
2014
6 p. 835-841
7 p.
artikel
123 Mouse models of adrenal tumorigenesis Hantel, Constanze
2010
6 p. 865-875
11 p.
artikel
124 Muscle and skeletal health in children and adolescents with GH deficiency Improda, Nicola
2016
6 p. 771-783
13 p.
artikel
125 Nonalcoholic fatty liver disease and adult growth hormone deficiency: An under-recognized association? Takahashi, Yutaka

6 p.
artikel
126 Non classical complications of primary hyperparathyroidism Chiodini, I.
2018
6 p. 805-820
artikel
127 Non-surgical management of primary hyperparathyroidism Cetani, Filomena
2018
6 p. 821-835
artikel
128 Novel approaches to the treatment of osteoporosis Appelman-Dijkstra, Natasha M.
2014
6 p. 843-857
15 p.
artikel
129 Nutritional aspects of bone health Rizzoli, René
2014
6 p. 795-808
14 p.
artikel
130 Parathyroid carcinoma Salcuni, Antonio Stefano
2018
6 p. 877-889
artikel
131 Parathyroid hormone resistance syndromes – Inactivating PTH/PTHrP signaling disorders (iPPSDs) Elli, Francesca Marta
2018
6 p. 941-954
artikel
132 Pathogenesis of benign adrenocortical tumors Vezzosi, Delphine
2010
6 p. 893-905
13 p.
artikel
133 Phaeochromocytomas and functional paragangliomas: Clinical management Plouin, Pierre-François
2010
6 p. 933-941
9 p.
artikel
134 Pharmacogenetics of osteoporosis Marini, Francesca
2014
6 p. 783-793
11 p.
artikel
135 Pheochromocytomas: The (pseudo)-hypoxia hypothesis Favier, Judith
2010
6 p. 957-968
12 p.
artikel
136 Pitfalls in hormone determinations Stenman, Ulf-Håkan
2013
6 p. 743-744
2 p.
artikel
137 Pitfalls in the measurement and interpretation of thyroid function tests Koulouri, Olympia
2013
6 p. 745-762
18 p.
artikel
138 Pituitary neuroendocrine tumors: from old treatments to innovations, from efficacy to tolerance, from benignity to carcinomas, where do we stand now? Castinetti, Frederic

6 p.
artikel
139 Preface Wiersinga, Wilmar M.
2009
6 p. vii-viii
nvt p.
artikel
140 Preface Reginster, Jean-Yves
2014
6 p. 765-
1 p.
artikel
141 Preface Pacini, Furio
2008
6 p. vii-
1 p.
artikel
142 Preface Bertagna, Xavier
2010
6 p. vii-
1 p.
artikel
143 Preface – Part 2: Circadian and endocrine rhythms Kalsbeek, Andries
2017
6 p. 519
artikel
144 Pregnancy and diabetes McCance, David R.
2011
6 p. 945-958
14 p.
artikel
145 Pregnancy and other pituitary disorders (including GH deficiency) Karaca, Zuleyha
2011
6 p. 897-910
14 p.
artikel
146 Primary Aldosteronism: what consensus for the diagnosis Cicala, Maria-Verena
2010
6 p. 915-921
7 p.
artikel
147 Prolactin and autoimmunity: The hormone as an inflammatory cytokine Borba, Vânia Vieira

6 p.
artikel
148 Prolactinoma in pregnancy Molitch, Mark E.
2011
6 p. 885-896
12 p.
artikel
149 Proper activation of MafA is required for optimal differentiation and maturation of pancreatic β-cells El Khattabi, Ilham
2015
6 p. 821-831
11 p.
artikel
150 Radio-iodine therapy in differentiated thyroid cancer: indications and procedures Reiners, Christoph
2008
6 p. 989-1007
19 p.
artikel
151 Receptor tyrosine kinase inhibitors in thyroid cancer Castellone, Maria Domenica
2008
6 p. 1023-1038
16 p.
artikel
152 Reprogramming of human exocrine pancreas cells to beta cells Staels, Willem
2015
6 p. 849-857
9 p.
artikel
153 Reprogramming of liver cells into insulin-producing cells Meivar-Levy, Irit
2015
6 p. 873-882
10 p.
artikel
154 Role of mitochondria in steroidogenesis Papadopoulos, Vassilios
2012
6 p. 771-790
20 p.
artikel
155 Role of thyroid ultrasound in the diagnostic evaluation of thyroid nodules Rago, Teresa
2008
6 p. 913-928
16 p.
artikel
156 Routine serum calcitonin measurement in the evaluation of thyroid nodules Elisei, Rossella
2008
6 p. 941-953
13 p.
artikel
157 Safety of long-term use of daily and long-acting growth hormone in growth hormone-deficient adults on cancer risk Boguszewski, Cesar Luiz

6 p.
artikel
158 Secondary osteoporosis: Pathophysiology & diagnosis Emkey, Gregory R.
2014
6 p. 911-935
25 p.
artikel
159 Second line treatment of acromegaly: Pasireotide or Pegvisomant? Chiloiro, Sabrina

6 p.
artikel
160 Selenium and thyroid Köhrle, Josef
2009
6 p. 815-827
13 p.
artikel
161 Serum thyroglobulin determination in thyroid cancer patients Francis, Zélia
2008
6 p. 1039-1046
8 p.
artikel
162 Sex steroids and the thyroid Tahboub, Rundsarah
2009
6 p. 769-780
12 p.
artikel
163 Skeletal muscle mitochondrial energetics in obesity and type 2 diabetes mellitus: Endocrine aspects Aguer, Céline
2012
6 p. 805-819
15 p.
artikel
164 Sperm genetic abnormalities and their contribution to embryo aneuploidy & miscarriage Rodrigo, Lorena

6 p.
artikel
165 Standardization of hormone determinations Stenman, Ulf-Håkan
2013
6 p. 823-830
8 p.
artikel
166 Surgical approaches in thyroid cancer and lymph-node metastases Dralle, Henning
2008
6 p. 971-987
17 p.
artikel
167 Temozolomide in aggressive pituitary tumours and pituitary carcinomas McCormack, Ann

6 p.
artikel
168 The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases Fallahi, Poupak

6 p.
artikel
169 The application of health technology assessment in osteoporosis Kanis, John A.
2014
6 p. 895-910
16 p.
artikel
170 The hormone melatonin: Animal studies Pevet, P.
2017
6 p. 547-559
artikel
171 The role of hormone therapy in urogenital health after menopause Nappi, Rossella E.

6 p.
artikel
172 The surgical management of sporadic primary hyperparathyroidism Egan, Richard J.
2018
6 p. 847-859
artikel
173 The value of positron emission tomography (PET) in the management of patients with thyroid cancer Robbins, Richard J.
2008
6 p. 1047-1059
13 p.
artikel
174 Thyroid disease in pregnancy Negro, Roberto
2011
6 p. 927-943
17 p.
artikel
175 Thyroid gland and brain: Enigma of Hashimoto's encephalopathy Churilov, Leonid P.

6 p.
artikel
176 Traumatic brain injury, abnormal growth hormone secretion, and gut dysbiosis Armstrong, Peyton A.

6 p.
artikel
177 Treatment of growth hormone deficiency in children, adolescents and at the transitional age Richmond, Erick
2016
6 p. 749-755
7 p.
artikel
178 Treatment of hypoparathyroidism Tecilazich, Francesco
2018
6 p. 955-964
artikel
179 Treatment of primary aldosteronism Quinkler, Marcus
2010
6 p. 923-932
10 p.
artikel
180 Treatments of psychiatric disorders, hyperprolactinemia and dopamine agonists Chanson, Philippe

6 p.
artikel
181 Twenty years' experience with post-Chernobyl thyroid cancer Williams, Dillwyn
2008
6 p. 1061-1073
13 p.
artikel
182 Tyrosine kinase inhibitors and the thyroid Sherman, Steven I.
2009
6 p. 713-722
10 p.
artikel
183 Uncoupling and reactive oxygen species (ROS) – A double-edged sword for β-cell function? “Moderation in all things” Collins, Sheila
2012
6 p. 753-758
6 p.
artikel
184 Unusual and lesser-known rare causes of adult growth hormone deficiency Das, Liza

6 p.
artikel
                             184 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland